Market Indices
Sector Heatmap
PCRX — Pacira BioSciences, Inc. Common Stock
NasdaqPacira BioSciences, Inc. Common Stock
- O
- 25.05
- H
- 26.00
- L
- 24.99
- V
- 802.72K
PCRX — Latest News & Headlines
11 StoriesPacira BioSciences (PCRX) Stock Looks Expensive Relative To Its Earnings Power - Simply Wall Street
Pacira BioSciences (PCRX) Stock Looks Expensive Relative To Its Earnings Power Simply Wall Street
Pacira BioSciences (PCRX) On Its Molteni Deal And The Undervalued Narrative - Yahoo Finance
Pacira BioSciences (PCRX) On Its Molteni Deal And The Undervalued Narrative Yahoo Finance
A postsurgery pain medicine is planned to launch in four countries; first sales are expected in 2027. - Stock Titan
A postsurgery pain medicine is planned to launch in four countries; first sales are expected in 2027. Stock Titan
PCRX Maintained by Truist Securities -- Price Target Raised to $31 - GuruFocus
PCRX Maintained by Truist Securities -- Price Target Raised to $31 GuruFocus
Technical Reactions to PCRX Trends in Macro Strategies - Stock Traders Daily
Technical Reactions to PCRX Trends in Macro Strategies Stock Traders Daily
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal - Zacks Investment Research
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal Zacks Investment Research
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal - Yahoo Finance
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal Yahoo Finance
76% of surveyed caregivers worried about the first days of home recovery - Stock Titan
76% of surveyed caregivers worried about the first days of home recovery Stock Titan
How Investors Are Reacting To Pacira BioSciences Stock Europe Distribution Deal - Simply Wall Street
How Investors Are Reacting To Pacira BioSciences Stock Europe Distribution Deal Simply Wall Street
Pacira BioSciences partners with Molteni for European expansion By Investing.com - Investing.com South Africa
Pacira BioSciences partners with Molteni for European expansion By Investing.com Investing.com South Africa
Pacira BioSciences stock weighs Q2 growth and lower guidance - AD HOC NEWS
Pacira BioSciences stock weighs Q2 growth and lower guidance AD HOC NEWS